Rocket Pharmaceuticals Correlations

RCKT Stock

USD 9.52 0.16 1.71%

The current 90-days correlation between Rocket Pharmaceuticals and Uniqure NV is 0.08 (i.e., Significant diversification). The correlation of Rocket Pharmaceuticals is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak. If the correlation is 0, the equities are not correlated; they are entirely random.

Rocket Pharmaceuticals Correlation With Market

Average diversification

The correlation between Rocket Pharmaceuticals and DJI is 0.15 (i.e., Average diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Rocket Pharmaceuticals and DJI in the same portfolio, assuming nothing else is changed.

Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Rocket Pharmaceuticals. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in industry.

For more information on how to buy Rocket Stock please use our How to Invest in Rocket Pharmaceuticals guide.

Moving together with Rocket Stock

0.64	ILMN	Illumina	Pair Corr
0.8	INZY	Inozyme Pharma	Pair Corr
0.72	KURA	Kura Oncology	Pair Corr
0.93	ABOS	Acumen Pharmaceuticals	Pair Corr
0.92	ADTX	Aditxt Inc	Pair Corr
0.87	STRO	Sutro Biopharma	Pair Corr
0.94	TCRX	Tscan Therapeutics	Pair Corr
0.84	TERN	Terns Pharmaceuticals	Pair Corr
0.89	CRNX	Crinetics Pharmaceuticals	Pair Corr
0.74	CTMX	CytomX Therapeutics	Pair Corr
0.81	DAWN	Day One Biopharmaceu	Pair Corr
0.64	TLKMF	Telkom Indonesia Tbk	Pair Corr

Moving against Rocket Stock

0.68	OPT	Opthea	Pair Corr
0.67	PHGE	Biomx Inc	Pair Corr
0.62	LTRN	Lantern Pharma	Pair Corr
0.57	GANX	Gain Therapeutics	Pair Corr
0.55	PFE	Pfizer Inc Aggressive Push	Pair Corr
0.47	CUE	Cue Biopharma	Pair Corr
0.44	FENC	Fennec Pharmaceuticals	Pair Corr
0.39	A	Agilent Technologies	Pair Corr
0.69	DBVT	DBV Technologies Earnings Call This Week	Pair Corr
0.57	CGTX	Cognition Therapeutics	Pair Corr
0.38	CPRX	Catalyst Pharmaceuticals	Pair Corr
0.85	OBI	Ondine Biomedical	Pair Corr
0.76	SSNLF	Samsung Electronics	Pair Corr
0.67	GPI	Group 1 Automotive	Pair Corr
0.62	EC	Ecopetrol SA ADR	Pair Corr

Related Correlations Analysis

	QURE	RYTM	SLDB	MGTX	PCVX	LRMR	SNDX	MRUS	STRO	STOK
QURE		-0.38	-0.6	-0.06	-0.35	-0.64	-0.79	-0.54	-0.73	-0.17	QURE
RYTM	-0.38		0.12	0.08	0.55	0.47	0.57	0.26	0.6	0.51	RYTM
SLDB	-0.6	0.12		0.26	0.07	0.59	0.57	0.89	0.52	0.12	SLDB
MGTX	-0.06	0.08	0.26		-0.19	-0.27	0.46	0.4	-0.19	-0.25	MGTX
PCVX	-0.35	0.55	0.07	-0.19		0.63	0.39	0.12	0.7	0.7	PCVX
LRMR	-0.64	0.47	0.59	-0.27	0.63		0.51	0.47	0.92	0.71	LRMR
SNDX	-0.79	0.57	0.57	0.46	0.39	0.51		0.64	0.63	0.27	SNDX
MRUS	-0.54	0.26	0.89	0.4	0.12	0.47	0.64		0.48	0.09	MRUS
STRO	-0.73	0.6	0.52	-0.19	0.7	0.92	0.63	0.48		0.67	STRO
STOK	-0.17	0.51	0.12	-0.25	0.7	0.71	0.27	0.09	0.67		STOK
	QURE	RYTM	SLDB	MGTX	PCVX	LRMR	SNDX	MRUS	STRO	STOK

Click cells to compare fundamentals

Check Volatility

Backtest Portfolio

Please upgrade your account to get full access to Macroaxis premium features

Correlation Matchups

Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.

High positive correlations

STRO	+ 0.92	LRMR
MRUS	+ 0.89	SLDB
STOK	+ 0.71	LRMR
STRO	+ 0.7	PCVX
STOK	+ 0.7	PCVX
STOK	+ 0.67	STRO

High negative correlations

SNDX	- 0.79	QURE
STRO	- 0.73	QURE
LRMR	- 0.64	QURE
SLDB	- 0.6	QURE
MRUS	- 0.54	QURE
RYTM	- 0.38	QURE

Risk-Adjusted Indicators

There is a big difference between Rocket Stock performing well and Rocket Pharmaceuticals Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Rocket Pharmaceuticals' multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.

	Mean Deviation	Jensen Alpha	Sortino Ratio	Treynor Ratio	Semi Deviation	Expected Shortfall	Potential Upside	Value @Risk	Maximum Drawdown
QURE	5.71	1.73	0.35	7.07	4.14	(7.55)	12.99	(9.75)	122.59
RYTM	1.70	(0.16)	0.00	(1.04)	0.00	0.00	3.55	(3.57)	13.95
SLDB	4.71	0.30	0.06	(0.92)	4.67	(6.07)	11.61	(8.68)	38.78
MGTX	2.60	0.35	0.10	(3.12)	3.08	(2.73)	5.56	(5.15)	15.50
PCVX	2.11	(0.11)	0.00	(0.09)	0.00	0.00	3.63	(3.97)	18.24
LRMR	3.40	(1.06)	0.00	(0.58)	0.00	0.00	6.61	(6.53)	29.16
SNDX	2.27	0.02	0.01	0.03	2.89	(2.37)	5.59	(4.75)	12.74
MRUS	2.10	0.09	0.04	(0.14)	2.58	(2.35)	5.15	(4.78)	15.98
STRO	3.35	(0.68)	0.00	(0.68)	0.00	0.00	4.89	(10.05)	20.35
STOK	3.37	(0.40)	0.00	(0.32)	0.00	0.00	7.03	(9.08)	27.59

Rocket Pharmaceuticals Corporate Management

CPA CPA	VP, Officer	Profile
Mayo Pujols	Chief Officer	Profile
Martin JD	Chief Counsel	Profile
Carlos Martin	Chief Officer	Profile
Jonathan Schwartz	Chief Medical Officer	Profile
Aaron Ondrey	Chief Officer	Profile
Isabel JD	Senior Officer	Profile

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC